Generation of induced pluripotent stem cell line ISMMSi060-A from a patient with combined oxidative phosphorylation deficiency 25.

Stem Cell Res

Division of Genetics and Metabolism - Department of Pediatrics, Center of Human Genomics and Precision Medicine, University of Wisconsin - School of Medicine and Public Health, USA; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address:

Published: January 2025

We have described a novel mitochondrial disorder caused by biallelic pathogenic variants in the methionyl-tRNA synthetase 2 gene (MARS2), now termed Combined oxidative phosphorylation deficiency 25 (COXPD25). This study focuses on the generation and characterization of induced pluripotent stem cells (iPSCs) from fibroblasts of a patient with COXPD25. The resulting iPSC line ISMMSi060-A, carries the compound heterozygous variants c.550C > T; p.Gln184* and c.424C > T; p.Arg142Trp in MARS2. The iPSCs exhibited normal cell morphology, expression of pluripotency markers, genome integrity, and the ability to differentiate.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scr.2025.103662DOI Listing

Publication Analysis

Top Keywords

induced pluripotent
8
pluripotent stem
8
combined oxidative
8
oxidative phosphorylation
8
phosphorylation deficiency
8
generation induced
4
stem cell
4
cell ismmsi060-a
4
ismmsi060-a patient
4
patient combined
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!